These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 20006858

  • 1. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.
    Eissa S, Swellam M, Shehata H, El-Khouly IM, El-Zayat T, El-Ahmady O.
    J Urol; 2010 Feb; 183(2):493-8. PubMed ID: 20006858
    [Abstract] [Full Text] [Related]

  • 2. Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer.
    Eissa S, Swellam M, Ali-Labib R, Mansour A, El-Malt O, Tash FM.
    J Urol; 2007 Sep; 178(3 Pt 1):1068-72. PubMed ID: 17644139
    [Abstract] [Full Text] [Related]

  • 3. Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs.
    Eissa S, Kassim SK, Labib RA, El-Khouly IM, Ghaffer TM, Sadek M, Razek OA, El-Ahmady O.
    Cancer; 2005 Apr 01; 103(7):1356-62. PubMed ID: 15717321
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.
    Moussa O, Abol-Enein H, Bissada NK, Keane T, Ghoneim MA, Watson DK.
    J Urol; 2006 Jun 01; 175(6):2312-6. PubMed ID: 16697865
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic evaluation of apoptosis inhibitory gene and tissue inhibitor matrix metalloproteinase-2 in patients with bladder cancer.
    Eissa S, Shabayek MI, Ismail MF, El-Allawy RM, Hamdy MA.
    IUBMB Life; 2010 May 01; 62(5):394-9. PubMed ID: 20408180
    [Abstract] [Full Text] [Related]

  • 6. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
    Nouraee N, Mowla SJ, Ozhand A, Parvin M, Ziaee SA, Hatefi N.
    Urol J; 2009 May 01; 6(2):101-8. PubMed ID: 19472128
    [Abstract] [Full Text] [Related]

  • 7. Urinary survivin mRNA expression and urinary nuclear matrix protein 22 BladderChek® and urine cytology in the detection of transitional cell carcinoma of the bladder.
    Al-Maghrebi M, Kehinde EO, Kapila K, Anim JT.
    Med Princ Pract; 2012 May 01; 21(3):295-7. PubMed ID: 22236881
    [Abstract] [Full Text] [Related]

  • 8. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L, Bialkowska-Hobrzanska H, Bukala B, Nott L, Razvi H.
    Can J Urol; 2004 Dec 01; 11(6):2438-44. PubMed ID: 15636669
    [Abstract] [Full Text] [Related]

  • 9. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
    Klein A, Zemer R, Buchumensky V, Klaper R, Nissenkorn I.
    Cancer; 1998 Jan 15; 82(2):349-54. PubMed ID: 9445193
    [Abstract] [Full Text] [Related]

  • 10. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S, Swellam M, Sadek M, Mourad MS, El Ahmady O, Khalifa A.
    J Urol; 2002 Aug 15; 168(2):465-9. PubMed ID: 12131289
    [Abstract] [Full Text] [Related]

  • 11. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
    Guo B, Luo C, Xun C, Xie J, Wu X, Pu J.
    Exp Oncol; 2009 Mar 15; 31(1):43-7. PubMed ID: 19300416
    [Abstract] [Full Text] [Related]

  • 12. Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer.
    Eissa S, Zohny SF, Swellam M, Mahmoud MH, El-Zayat TM, Salem AM.
    Clin Biochem; 2008 Nov 15; 41(16-17):1335-41. PubMed ID: 18804101
    [Abstract] [Full Text] [Related]

  • 13. The diagnostic efficacy of urinary survivin and hyaluronidase mRNA as urine markers in patients with bladder cancer.
    Eissa S, Badr S, Barakat M, Zaghloul AS, Mohanad M.
    Clin Lab; 2013 Nov 15; 59(7-8):893-900. PubMed ID: 24133921
    [Abstract] [Full Text] [Related]

  • 14. A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot.
    Eissa S, Swellam M, Labib RA, El-Zayat T, El Ahmady O.
    J Urol; 2009 Mar 15; 181(3):1353-60. PubMed ID: 19185322
    [Abstract] [Full Text] [Related]

  • 15. Primary application study in early diagnosis of bladder cancer by survivin molecular beacons.
    Zhao J, He D, He H, Li L, Zhang LL, Wang XY.
    Urology; 2007 Jul 15; 70(1):60-4. PubMed ID: 17656209
    [Abstract] [Full Text] [Related]

  • 16. Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1.
    Lokeshwar VB, Young MJ, Goudarzi G, Iida N, Yudin AI, Cherr GN, Selzer MG.
    Cancer Res; 1999 Sep 01; 59(17):4464-70. PubMed ID: 10485499
    [Abstract] [Full Text] [Related]

  • 17. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer.
    Yu J, Zhu T, Wang Z, Zhang H, Qian Z, Xu H, Gao B, Wang W, Gu L, Meng J, Wang J, Feng X, Li Y, Yao X, Zhu J.
    Clin Cancer Res; 2007 Dec 15; 13(24):7296-304. PubMed ID: 18094410
    [Abstract] [Full Text] [Related]

  • 18. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
    Yie SM, Lou B, Ye SR, Cao M, He X, Li P, Hu K, Rao L, Wu SM, Xiao HB, Gao E.
    Ann Surg Oncol; 2008 Nov 15; 15(11):3073-82. PubMed ID: 18670822
    [Abstract] [Full Text] [Related]

  • 19. Analysis of fluorescence in situ hybridization, mtDNA quantification, and mtDNA sequence for the detection of early bladder cancer.
    Yoo JH, Suh B, Park TS, Shin MG, Choi YD, Lee CH, Choi JR.
    Cancer Genet Cytogenet; 2010 Apr 15; 198(2):107-17. PubMed ID: 20362225
    [Abstract] [Full Text] [Related]

  • 20. Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection.
    Neves M, Ciofu C, Larousserie F, Fleury J, Sibony M, Flahault A, Soubrier F, Gattegno B.
    J Urol; 2002 Mar 15; 167(3):1276-81. PubMed ID: 11832713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.